Haemonetics Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Haemonetics Corp Unternehmen

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Haemonetics Corp Informationen



BörsenkürzelHAE

Name des UnternehmensHaemonetics Corp

IPO-datumOct 17, 1979

CEOMr. Christopher A. Simon

Anzahl der mitarbeiter3023

WertpapierartOrdinary Share

GeschäftsjahresendeOct 17

Addresse125 Summer Street

StadtBOSTON

BörseNYSE Consolidated

LandUnited States of America

Postleitzahl02110

Telefon17818487100

Websitehttps://www.haemonetics.com

BörsenkürzelHAE

IPO-datumOct 17, 1979

CEOMr. Christopher A. Simon

Führungskräfte von Haemonetics Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.01K

-0.84%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

Mr. Michael J. Coyle

Independent Director

15.39K

+21.20%

Ms. Diane M. Bryant

Independent Director

7.13K

+60.75%

Mr. Roy Galvin

Executive Vice President, Chief Commercial Officer

3.24K

-4.28%

Mr. Frank W. Chan

Chief Operating Officer, Executive Vice President

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.01K

-0.84%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

Keine Daten

Nach RegionUSD

Name

Umsatz

Anteil

United States

242.40M

75.42%

Europe

40.88M

12.72%

Asia

21.65M

6.74%

Japan

13.65M

4.25%

other

2.81M

0.87%

Nach Geschäftsbereich

Nach Region

Keine Daten

Aktionärsstatistik

Aktualisiert: Sat, Nov 8

Aktionäre

Aktionärstypen

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

11.90%

The Vanguard Group, Inc.

10.30%

Neuberger Berman, LLC

9.14%

Wellington Management Company, LLP

4.59%

State Street Investment Management (US)

4.02%

Andere

60.05%

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

11.90%

The Vanguard Group, Inc.

10.30%

Neuberger Berman, LLC

9.14%

Wellington Management Company, LLP

4.59%

State Street Investment Management (US)

4.02%

Andere

60.05%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

52.23%

Investment Advisor/Hedge Fund

49.81%

Research Firm

4.18%

Hedge Fund

3.57%

Bank and Trust

1.38%

Pension Fund

1.36%

Individual Investor

1.19%

Sovereign Wealth Fund

1.10%

Insurance Company

0.03%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

697

54.60M

116.65%

-5.18M

2025Q2

700

57.31M

118.95%

-4.19M

2025Q1

723

57.94M

120.44%

-3.07M

2024Q4

701

58.48M

116.40%

-1.44M

2024Q3

689

57.60M

112.60%

-1.51M

2024Q2

668

57.60M

113.31%

+3.07M

2024Q1

655

52.49M

103.35%

-1.26M

2023Q4

647

51.85M

102.19%

-3.31M

2023Q3

657

52.00M

102.54%

-4.11M

2023Q2

656

51.75M

102.38%

-4.68M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

5.57M

11.56%

-96.61K

-1.71%

Jun 30, 2025

The Vanguard Group, Inc.

4.94M

10.26%

-145.60K

-2.86%

Jun 30, 2025

Neuberger Berman, LLC

4.28M

8.88%

-70.91K

-1.63%

Jun 30, 2025

Wellington Management Company, LLP

2.15M

4.46%

-478.59K

-18.23%

Jun 30, 2025

State Street Investment Management (US)

1.88M

3.91%

-34.03K

-1.77%

Jun 30, 2025

River Road Asset Management, LLC

1.66M

3.44%

+260.62K

+18.68%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

1.59M

3.31%

-600.70K

-27.36%

Jun 30, 2025

Royce Investment Partners

1.27M

2.64%

+109.76K

+9.45%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.24M

2.58%

+23.26K

+1.90%

Jun 30, 2025

Capital Research Global Investors

1.14M

2.36%

-438.28K

-27.79%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Sun, Nov 2

Name

Anteil

SPDR S&P Health Care Equipment ETF

1.49%

Harbor Human Capital Factor US Small Cap ETF

1.48%

Neuberger Berman Small-Mid Cap ETF

1.36%

First Trust Mid Cap US Equity Select ETF

0.68%

First Trust Small Cap US Equity Select ETF

0.64%

Lattice Hartford Multifactor Small Cap ETF

0.51%

WisdomTree US SmallCap Quality Growth Fund

0.29%

VictoryShares US Small Mid Cap Value Momentum ETF

0.26%

Royce Quant Small-Cap Quality Value ETF

0.25%

First Trust Small Cap Growth AlphaDEX Fund

0.24%

SPDR S&P Health Care Equipment ETF

Anteil1.49%

Harbor Human Capital Factor US Small Cap ETF

Anteil1.48%

Neuberger Berman Small-Mid Cap ETF

Anteil1.36%

First Trust Mid Cap US Equity Select ETF

Anteil0.68%

First Trust Small Cap US Equity Select ETF

Anteil0.64%

Lattice Hartford Multifactor Small Cap ETF

Anteil0.51%

WisdomTree US SmallCap Quality Growth Fund

Anteil0.29%

VictoryShares US Small Mid Cap Value Momentum ETF

Anteil0.26%

Royce Quant Small-Cap Quality Value ETF

Anteil0.25%

First Trust Small Cap Growth AlphaDEX Fund

Anteil0.24%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten